Response to Pham et al., "More data are needed to confirm the utility of screening for atypical fibroxanthoma and pleomorphic dermal sarcoma recurrence"

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › fagfællebedømt

Præsentation
Citationsformater

Mathias Ørholt
Eriksson, Frank
Herly, Mikkel
Vester-Glowinski, Peter Viktor

To the Editor: We thank Pham et al1 for their interest in our study on patients with atypical fibroxanthoma (AFX) and pleomorphic dermal sarcoma (PDS),2 and we appreciate the opportunity to discuss and clarify our analysis further.

Originalsprog	Engelsk
Tidsskrift	Journal of the American Academy of Dermatology
Vol/bind	90
Udgave nummer	5
Sider (fra-til)	e175-e176
Antal sider	2
ISSN	0190-9622
DOI	https://doi.org/10.1016/j.jaad.2023.12.042
Status	Udgivet - 2024

ID: 385888993